4.7 Article

Microbiological and genotypic analysis of methicillin-resistant Staphylococcus aureus bacteremia

期刊

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 52, 期 9, 页码 3441-3443

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00357-08

关键词

-

资金

  1. Cubist Pharmaceuticals (Lexington, MA)
  2. American Heart Association
  3. National Institute of General Medical Sciences [GM080602]

向作者/读者索取更多资源

In a recent landmark trial of bacteremia caused by methicillin-resistant Staphylococcus aureus (MRSA) isolates, vancomycin MICs were >= 1 mu g/ml for only 16% of the isolates, and accessory gene regulator (agr) function as measured by delta-hemolysin activity was absent or reduced in only 28.1% of the isolates. This clinical study did not capture a population of MRSA isolates predictive of vancomycin treatment failure.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据